S-(2-羟基-5-硝基苄基)-6-硫代肌苷结构式
|
常用名 | S-(2-羟基-5-硝基苄基)-6-硫代肌苷 | 英文名 | S-(2-HYDROXY-5-NITROBENZYL)-6-THIOINOSINE |
|---|---|---|---|---|
| CAS号 | 56964-73-9 | 分子量 | 435.41100 | |
| 密度 | 1.87g/cm3 | 沸点 | 829.7ºC at 760mmHg | |
| 分子式 | C17H17N5O7S | 熔点 | N/A | |
| MSDS | 中文版 美版 | 闪点 | 455.6ºC | |
| 符号 |
GHS07 |
信号词 | Warning |
| 中文名 | S-(2-羟基-5-硝基苄基)-6-硫肌苷 |
|---|---|
| 英文名 | 6-[(2-Hydroxy-5-nitrobenzyl)thio]-9-β-D-ribofuranosylpurine |
| 英文别名 | 更多 |
| 密度 | 1.87g/cm3 |
|---|---|
| 沸点 | 829.7ºC at 760mmHg |
| 分子式 | C17H17N5O7S |
| 分子量 | 435.41100 |
| 闪点 | 455.6ºC |
| 精确质量 | 435.08500 |
| PSA | 204.87000 |
| LogP | 0.86710 |
| 折射率 | 1.83 |
| 符号 |
GHS07 |
|---|---|
| 信号词 | Warning |
| 危害声明 | H315-H319-H335 |
| 警示性声明 | P261-P305 + P351 + P338 |
| 个人防护装备 | dust mask type N95 (US);Eyeshields;Gloves |
| 危害码 (欧洲) | Xi |
| 风险声明 (欧洲) | 36/37/38 |
| 安全声明 (欧洲) | 26-36 |
| 危险品运输编码 | NONH for all modes of transport |
|
Constrained NBMPR analogue synthesis, pharmacophore mapping and 3D-QSAR modeling of equilibrative nucleoside transporter 1 (ENT1) inhibitory activity.
Bioorg. Med. Chem. 16 , 3848-65, (2008) Conformationally constrained analogue synthesis was undertaken to aid in pharmacophore mapping and 3D-QSAR analysis of nitrobenzylmercaptopurine riboside (NBMPR) congeners as equilibriative nucleoside... |
|
|
Inhibitors of nucleoside transport. A structure-activity study using human erythrocytes.
J. Med. Chem. 18 , 968, (1975) The passage of nucleosides across the plasma membrane of erythrocytes is a membrane-mediated process which is strongly inhibited by derivatives of 9-beta-D-ribofuranosylpurine (1) with S, O, or N atom... |
| (2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[(2-hydroxy-5-nitrophenyl)methylsulfanyl]purin-9-yl]oxolane-3,4-diol |
查看所有供应商和价格请点击：